Log In
Print
BCIQ
Print
Print this Print this
 

Oral rigosertib (Estybon) (ON 01910.Na, SyB C-1101)

  Manage Alerts
Collapse Summary General Information
Company Onconova Therapeutics Inc.
DescriptionOral dual inhibitor of phosphoinositide 3-kinase (PI3K) and polo-like kinase 1 (PLK1; STPK13)
Molecular Target Phosphoinositide 3-kinase (PI3K) ; Polo-like kinase 1 (PLK1) (STPK13)
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) inhibitor; Polo-like kinase 1 (PLK1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today